Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the efficacy and safety of generic semaglutide compared to innovator semaglutide in Indian adults with type 2 diabetes inadequately controlled on metformin, finding non-inferior results.
This study evaluated the addition of glargine, glimepiride, liraglutide, or sitagliptin to metformin in type 2 diabetes. It found varying rates of hypoglycemia among the different treatments.
Semaglutide and dulaglutide administered weekly to adults with type 2 diabetes and obesity.
Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
This study evaluated the impact of green tea extract on glycemic and lipid profiles in patients with type 2 diabetes, finding significant improvements in several metabolic markers.
This study evaluated the Greenhabit mobile app for enhancing self-management in type 2 diabetes. Results showed significant improvements in several health metrics compared to standard care.
This study investigated the effects of GLP-1 receptor agonists, liraglutide and semaglutide, on cardiovascular outcomes in diabetes, finding significant reductions in major adverse cardiovascular events.
This study evaluated two health education apps for diabetes management, finding varying levels of user satisfaction and knowledge improvement.
This study evaluated the effectiveness of the Health Storylines mAPP for self-management among individuals with chronic illnesses in Baguio City, Philippines, finding no significant differences in self-management scores.
This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
